血管紧张素受体拮抗剂基础及临床研究新进展
江华,刘国伟,罗英儒
摘要(Abstract)：
血管紧张素受体拮抗剂是一类新型、高效、口服吸收的抗高血压药物 ,近期研究显示对高血压病人除具有良好的降压作用外还有其他优势 :减少左心室肥大 ,提高心脏收缩功能 ,延缓肾功能不全进程及脑、肝保护功能 ,具有广阔的应用前景
关键词(KeyWords)：
血管紧张素受体拮抗剂;综述
基金项目(Foundation):
作者(Author):
江华,刘国伟,罗英儒
参考文献(References)：
- 1TimmermansPB ,WongPC ,ChiuAT ,etal.AngiotensinⅡreceptorantagonists.PharmacolRev.1993,45:205～207
- 2DeGasparo,HussainA ,AlexanderW ,etal.Proposedupdateofangiotensinreceptornomenclature.Hypertension.1995,25:924
- 3BauerJH ,ReamsGP .TheangiotensinⅡtype1receptoran tagonists.ArchInternMed.1995,155:1361～1365
- 4CarrAA ,PrisantLM .Losartan:firstofanewclassofan giotensinantagonistsforthemanagementofhypertension.JClinPharmacol.1995,36:3～9
- 5SchmitzD ,BerkBC .AngiotensinⅡsignaltransductionstimu lationofmultiplemitogenactivatedproteinkinasepathways.TrendsendocrinolMetab.1997,8:261～266
- 6UrataH ,BoehmK ,PhilipA ,etal.Humanchymase:cellularlocalizationandregionaldistributionofamajorangiotensinⅡ formingenzymeintheheart.JClinInvest.1993,91:1269～1281
- 7MunafoA ,ChristenY ,NussbergerJ ,etal.Drugconcentra tionresponserelationshipsinnormalvolunteersafteroralad ministrationoflosartanangiotensinⅡreceptorantagonist.ClinPharmacolTher1992,51:513～512
- 8BrunnerHR ,NussbergerJ ,WaeberB ,etal.Dose responsere lationshipsofACEinhibitorsandangiotensinⅡblockers.EurHeartJ 1994,15(supplD):123～128
- 9SicaDA ,HalstensonCE ,GehrTW ,etal.Pharmacokineticsandbloodpressureresponseoflosartaninend stagerenaldis ease.ClinPharmacokinet.2000,38:519～526
- 10IsrailiZH .ClinicalpharmacokineticsofangiotensinⅡ(AT1)receptorblockersinhyertension.JHumHypertens.2000,14suppl1:S73～86
- 11ShobhaJC ,KumarTR ,RajuBS ,etal.Evaluationofefficacyandsafetyoflosartanpotassiuminthetreatmentofmildtomoderatehypertensionascomparedtoenalaprilmaleate.JAssocPhysiciansIndia.2000,48:497～500
- 12MonterrosoVH ,RodriguezChavezV ,CarbajalET ,Useofambulatorybloodpressuremonitoringtocompareantihyper tensiveefficacyandsafetyoftwoangiotensinⅡreceptoran tagonists,losartanandvalsartan.LosartanTrialInvestiga tors.Adv.Ther2000,17:117～131
- 13CavasinMA ,YangXP ,LinYH ,etal.EffectsofACEin hibitor,AT1antagonist,andcombinedtreatmentinmicewithheartfailure.JCardiovascPharmacol.2000,36:472～480
- 14AvanzaAC ,ElAouarLM ,MillJG .Reductioninleftventric ularhypertrophyinhypertensive patientstreatedwithenalapril,losartanorthecombinationofenalaprilandlosar tan.ArqBrasCardiol.2000,74:103～117
- 15GremmlerB ,KunertM ,SchleitinhH ,etal.ImprovementofcardiacoutputinpatientswithsevereheartfailurebyuseofACE inhibitorscombinedwiththeAT1 antagonisteprosartan,EurJHeartFail.2000,2:183～187
- 16FridmanK ,WyockiM ,FribergP ,etal.Candesartancilexetilandrenalhemodynamicsinhypertensivepatients.AmJHy pertens.2000,13:1045～1048
- 17ShihabFS ,BennettWM ,TannerA ,etal.AngiotensinⅡblockadedecreaseTGF β1,andmatrixproteinsincyclosorinenephropathy,KidneyInt.1997,52:600
- 18OikawaT ,FreemanM ,LoW ,etal.Modulationofplasmino genactivatorinhibitor linvivo:anewmechanismforthean ti fibroticeffectofreninangiotensininhibition.KidInt.1997,51:164～172
- 19LacourciereY ,BelangerA ,GodinC ,etal.Long termcom parisonoflosartanandenalaprilonkidneyfunctioninhyper tensivetype2diabeticswithearlynephropathy.kidneyInt.2000,58:762～769
- 20UngerT ,Inhibitingrenin angiotensininthebrain:thepossibletherapeuticimplications.BloodPress.2001,10Suppl1:12～16
- 21BlezerEl.NicolayK ,koomansHA ,etal.Losartanversusenalapriloncerebraledemaandproteinuriainstroke pronehypertensiverats.AmJHypertens.2001,14:54～61
- 22ArvedWS ,JonhanFK ,ChristionPK .Effectoflosartan,anangiotensionⅡreceptorantagonistonportalpressureincir rhosis.Hepatology.1999,29:334～339
- 23YanJP ,JiaJB ,MaxH ,etal.Immunohistochemicalstudyonexpressionofepidermalgrowthfactorreceptorathepatocytenucleiinexperimentalratlivercirrhosis.WorldJGastroen tero.1998,4:143
- 24CampistolJM ,InigoP ,JimenezW ,etal.LosartandecreasesplasmalevelsofTGF betalintransplant patientswithchronicallograftnephrophy.KidneyInt.1999,56:714～719
- 25李文歌,陈香美,叶一舟,等血管紧张素Ⅱ1型受体抑制成纤维细胞增殖和纤维连接蛋白分泌中华医学杂志.1998,78:738～740